Our Health Library information does not replace the advice of a doctor. Please be advised that this information is made available to assist our patients to learn more about their health. Our providers may not see and/or treat all topics found herein.

Stages of Chronic Kidney Disease

Overview

The stages of chronic kidney disease are determined mostly by the estimated glomerular filtration rate (eGFR). Glomerular filtration is the process by which the kidneys filter the blood, removing excess wastes and fluids. The eGFR is a calculation that determines how well the blood is filtered by the kidneys. It is one way to measure kidney function. Your doctor will also use a test that measures the amount of protein in your urine and the cause of your kidney disease to guide your treatment.

The eGFR is often calculated using a formula that includes a person's age, sex, and serum creatinine levels. An eGFR under 60 mL/min/1.73 m² may indicate kidney disease. The lower the eGFR number, the worse the kidney function. This number is an estimate. It may not be a good measure of kidney health in some people, such as the very young or very old, amputees, or obese people. In some cases, eGFR may also be estimated with a 24-hour urine collection.

Chronic kidney disease is defined as either kidney damage or an eGFR of less than 60 for longer than 3 months.

Stages of chronic kidney disease

Stage

Description

eGFR

What this means to you

1

Kidney damage without symptoms

90 or above

  • Your doctor will try to find the cause of your kidney disease and may begin treatment.
  • Manage other health problems, such as diabetes and high blood pressure.
  • See your doctor regularly to monitor your condition.

2

Mild decline in kidney function

60–89

  • Your doctor will estimate how quickly your disease is progressing.
  • Manage other health problems, such as diabetes and high blood pressure.
  • Continue regular monitoring.

3a

Moderate decline in kidney function

45–59

  • In stages 3a and 3b, your doctor may check for complications, such as anemia and bone disease, and begin treatment if needed.
  • Continue monitoring.

3b

Moderate to severe decline in kidney function

30-44

  • In stages 3a and 3b, your doctor may check for complications, such as anemia and bone disease, and begin treatment if needed.
  • Continue monitoring.

4

Severe decline in kidney function

15–29

  • Decide what type of treatment you want if kidney failure develops.
  • Continue treatment and monitoring.

5

Kidney failure

Below 15

  • Start dialysis, have a kidney transplant, or choose palliative care.
  • Continue to see your doctor for treatment and testing.

Credits

Current as of: October 11, 2023

Author: Ignite Healthwise, LLC Staff
Clinical Review Board
All Healthwise education is reviewed by a team that includes physicians, nurses, advanced practitioners, registered dieticians, and other healthcare professionals.

Current as of: October 11, 2023

Author: Ignite Healthwise, LLC Staff

Clinical Review Board
All Healthwise education is reviewed by a team that includes physicians, nurses, advanced practitioners, registered dieticians, and other healthcare professionals.

Dear patient

I am excited to announce that I will be relocating my practice to Houston Methodist DeBakey Cardiology Associates. Starting November 4, 2024, my new address will be:

Houston Methodist DeBakey Cardiology Associates
6550 Fannin St.
Smith Tower, Suite 1901
Houston, TX 77030

Please note that my phone number and fax number will also change to the following:
24-Hour Telephone: 713-441-1100
Fax: 713-790-2643
Clinical Support Telephone (M-F, 8-5): 713-441-3515

I am excited about caring for you in my new office and hope you will make the transition with me. I will also continue to refill your medications as I have in the past. To assist, please provide your pharmacy with my new contact information.

Please consider checking your prescription refills to verify that you have enough medication on hand to last you until your next visit. Please note that your medical records will remain at my former office until you authorize their transfer. If you choose for me to continue providing your medical care, please complete and sign the enclosed “Authorization for Release of Medical Records” form and fax it to 713-790-2643. Once we receive your authorization, we will be happy to process the request for you.

Thank you for entrusting me with your medical care. My new team and I are dedicated to making this transition as seamless as possible. For help scheduling an appointment and transitioning your care, please call my new office number above.

I look forward to continuing your care at my new location.

Sincerely,
Gopi A. Shah, MD

Dear patient

Dr. Albert Raizner, Dr. Michael Raizner, and Dr. Mohamed El-Beheary are excited to announce that our practice, Houston Cardiovascular Associates, will merge with Houston Cardiovascular Associates on November 1, 2024.

Our new offices are similarly located in Houston, near the Texas Medical Center and in Sugar Land. Our in-hospital care will continue at Houston Methodist Hospital in the Texas Medical Center and Houston Methodist Sugar Land Hospital. Importantly, our new offices expand our services with state-of-the-art equipment and amenities. Our core values will always be, as they began over 40 years ago when Dr. Albert Raizner founded HCA:

Integrity – Compassion – Accountability

Our new address and contact information are:

Your medical records are confidential and remain available at our new locations. We consider it a privilege to serve as your cardiologists and look forward to your continuing with us. However, should you desire to transfer to another physician, you may request a copy of your records by contacting us at our new addresses and phone numbers listed above.

We thank you for your trust and loyalty. As always, we will continue to be here to take care of you. Please do not hesitate to contact us if you have any questions or concerns.

Sincerely,

Dr. Albert Raizner,
Dr. Michael Raizner,
Dr. Mohamed El-Beheary